ACTN3 and MLCK genotype associations with exertional muscle damage.
Strenuous exercise results in damage to skeletal muscle that is manifested in delayed muscle pain, prolonged strength loss, and increases in muscle proteins in the blood, especially creatine kinase (CK) and myoglobin (Mb). Some individuals experience profound changes in these variables in response to standard laboratory exercise or recreational activities. We proposed that variations in genes coding for two myofibrillar proteins [alpha-actinin 3 (ACTN3) and myosin light chain kinase (MLCK)] may explain the large variability in the response to muscle-damaging exercise. We hypothesized that subjects with specific single nucleotide polymorphisms (SNPs) in ACTN3 and MLCK would show a greater loss in muscle strength and/or a greater increase in blood CK and Mb in response to eccentric exercise. Blood from 157 subjects who performed a standard elbow flexion eccentric exercise protocol was tested for association between genotypes of ACTN3 (1 SNP tested: R577X) and MLCK (2 SNPs tested: C49T and C37885A) and changes in blood CK and Mb and isometric strength. Subjects possessing the ACTN3-deficient genotype (XX) had lower baseline CK compared with the heterozygotes (P = 0.035). After the eccentric exercise, those subjects homozygous for the MLCK 49T rare allele had a significantly greater increase in CK and Mb (P < 0.01) compared with the heterozygotes, and those heterozygous for MLCK C37885A had a significantly greater increase in CK compared with the homozygous wild type (P < 0.05). There was only one subject homozygous for the rare MLCK 37885A allele. MLCK C37885A was also associated with postexercise strength loss (P < 0.05); the heterozygotes demonstrated greater strength loss compared with the homozygous wild type (CC). These results show that variations in genes coding for specific myofibrillar proteins influence phenotypic responses to muscle damaging exercise.
Clarkson
Priscilla M
PM
Dept. of Exercise Science, University of Massachusetts, Amherst, MA 01003, USA. clarkson@excsci.umass.edu
Hoffman
Eric P
EP
Zambraski
Edward
E
Gordish-Dressman
Heather
H
Kearns
Amy
A
Hubal
Monica
M
Harmon
Brennan
B
Devaney
Joseph M
JM
D000185:Actinin / Q000235:genetics*; D000328:Adult; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D008297:Male; D018482:Muscle, Skeletal / Q000503:physiopathology*; D010455:Peptides / Q000235:genetics*; D010641:Phenotype; D010807:Physical Endurance / Q000235:genetics*; D005082:Physical Exertion; D012206:Rhabdomyolysis / Q000503:physiopathology*
C118456:ACTN3 protein, human; D010455:Peptides; D000185:Actinin; C065738:MLCK peptide